October 1, 2022

Volume XII, Number 274

Research Misconduct and the False Claims Act: Navigating the Process and Preventing Liability (Intermediate)

With the increasing pressure on federal research budgets, government agencies and private whistleblowers are becoming more focused on how recipients of federal funds use and account for those dollars.

Inadvertent mistakes (or intentional misconduct) in complying with complicated grant requirements can expose children's hospitals and other research institutions to significant financial liability under the False Claims Act (FCA). In extreme circumstances research misconduct can also lead to criminal prosecution and a range of additional monetary penalties.

Recent settlements between the U.S. Department of Justice and colleges, universities, and academic medical centers demonstrate that these institutions cannot escape scrutiny of their research enterprise. Please join our panel of experts as we walk through the FCA risks and pitfalls associated with federally sponsored research.

Topics addressed during this webinar include:

  • Research misconduct compliance in academic and teaching institutions;

  • Nexus between research misconduct and the FCA;

  • Current enforcement trends and risk areas;

  • Reporting and disclosure obligations; and

  • Best practices for mitigating exposure to liability through the research enterprise.

Presenters include:

  • Karen Hartman, Administrator, Research Compliance, Integrity and Compliance Office, Mayo Clinic

  • Kurt Lindland, Assistant U.S. Attorney, Civil Division U.S. Attorney’s Office

  • Geoffrey M. Raux, Senior Counsel, Foley & Lardner LLP

  • Torrey K. Young (Moderator), Associate, Foley & Lardner LLP